Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

FDA approves first vaccine for prevention of rotaviral disease

Sep. 1, 1998

Genset enters into Chlamydia vaccine license agreement with AHP

Aug. 28, 1998

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

Aug. 26, 1998

Laboratory testing of new, more efficient Toleragen drug completed

Aug. 25, 1998

GeneMedicine reports progress in its development of dendritic cell-based genetic vaccines

Aug. 24, 1998

SB launches typhoid vaccine in first market

Aug. 20, 1998

Russian researchers describe immunomodulatory activity of thiethazole

Aug. 20, 1998

CellCept receives European approval for use in heart transplantation

Aug. 20, 1998

Kanebo reveals new immunosuppressants in the pipeline

Aug. 19, 1998

Cel-Sci reports herpes vaccines demonstrating efficacy in animals

Aug. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...